Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FHVQV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,973
Award facts
- Contract value 100% obligated
- $83,973.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $83,973.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ALYFTREK 10-50-125 mg tablets in quantities of 14. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and carries no set-aside designation. This award represents a discrete transaction issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total value of $500 million through November 2026.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement. The company specializes in distributing a comprehensive range of pharmaceutical products including prescription medications, biologics, and medical consumables to military and federal healthcare facilities nationwide. This delivery order exemplifies the company's core business model of providing medications and medical supplies directly to Department of Defense healthcare sites, continuing its consistent performance history with the DLA across an extensive portfolio of pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FHVQV?
SPE2DB25FHVQV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FHVQV worth?
The government has obligated $83,973 on SPE2DB25FHVQV.
Is contract SPE2DB25FHVQV an order under another contract?
Yes. SPE2DB25FHVQV is a delivery order under SPE2DB24D9230, an indefinite delivery contract.
Was contract SPE2DB25FHVQV competed?
The extent of competition for SPE2DB25FHVQV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award